Detection of Residual Pulmonary Vascular Obstruction by Ventilation-Perfusion Lung Scan Late After a First Pulmonary Embolism

Affiliation auteurs!!!! Error affiliation !!!!
TitreDetection of Residual Pulmonary Vascular Obstruction by Ventilation-Perfusion Lung Scan Late After a First Pulmonary Embolism
Type de publicationJournal Article
Year of Publication2017
AuteursChopard R, Genet B, Ecarnot F, Chatot M, Napporn G, Hyvert A, Didier-Petit K, Schiele F, Meneveau N
JournalAMERICAN JOURNAL OF CARDIOLOGY
Volume119
Pagination1883-1889
Date PublishedJUN 1
Type of ArticleArticle
ISSN0002-9149
Résumé

The long-term impact of persistent pulmonary vascular obstruction after pulmonary embolism (PE) remains unknown. Based on ventilation-perfusion lung scan performed at discharge and 3 months after a first PE, we aimed to investigate the, prognostic value on 5-year adverse events of (1) residual pulmonary vascular obstruction (RPVO) at discharge (DIS-RPVO), (2) RPVO at 3 months (3M-RPVO), and (3) relative change in RPVO between the 2 scans (RC-RPVO). We performed a prospective, multicenter cohort study from January 2007 to December 2009 including patients who survived at least 3 months after a PE. RC-RPVO was defined as (DIS-RPVO 3M-RPVO)/DIS-RPVO. The primary end point was a combined end point at 5 years, composed of all-cause death, recurrent venous thromboembolism, chronic thromboembolic pulmonary hypertension, heart failure, and rehospitalization for cardiac causes. Receiver-operating characteristic curves were computed to define thresholds of-DIS-RPV0, 3M-RPVO, and RC-RPVO predictive of the primary combined end point at 5 years. Overall, 241 patients were included (high-risk PE: 11.2%, intermediate-risk PE: 51.8%, low-risk PE: 37%). Mean DIS-RPVO was 27.9 15.1%, mean 3M-RPVO was 10.3 10.8%, and mean RC-RPVO was 61.7 33.4%. At 5 years, 112 patients (46.5%) experienced the combined end point. Both 3M-RPVO 1.5% and RC-RPVO 537.5% were independently related to the occurrence of the combined end point at 5 years (p = 0.01 and p = 0.02, respectively). DIS-RPVO did not predict long-term adverse events. In conclusion, RC-RPVO 537.5% and 3M-RPVO 1.5% were independently related to the occurrence of adverse events 5 years after a first PE. (C) 2017 Elsevier Inc. All rights reserved.

DOI10.1016/j.amjcard.2017.03.002